Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of TachoSil on Air Leakage in Chest Surgery
2007-006525-26Phase 3Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of tachosil in non-small cell lung cancer (NSCLC), intraoperative bleeding and air-leak syndrome (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Intensity of post-operative air leakage expressed as area under the curve (AUC). Started Jul 2008; status: completed.
02
Drugs
tachosil
03
Conditions
non-small cell lung cancer (NSCLC)intraoperative bleedingair-leak syndrome
Beyond the preview
Go deeper on 2007-006525-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006525-26.